Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells. - Frecot DI; Blaess S; Wagner TR; Kaiser PD; Traenkle B; Fandrich M; Jakobi M; Scholz AM; Nueske S; Schneiderhan-Marra N; Gouttefangeas C; Kneilling M; et al. (Frontiers in immunology, 2024)